A rating of 56 puts Fate Therapeutics Inc (FATE) near the top of the Healthcare sector according to InvestorsObserver.
Fate Therapeutics Inc's score of 56 means that it ranks higher than 56% of stocks in the sector. In addition, its overall score of 42 ranks it higher than 42% of all stocks.
FATE has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on FATE!
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.
Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Fate Therapeutics Inc Stock Today?
Fate Therapeutics Inc (FATE) stock is trading at $22.08 as of 3:16 PM on Wednesday, May 25, a rise of $0.94, or 4.45% from the previous closing price of $21.14. The stock has traded between $21.05 and $22.30 so far today. Volume today is 1,317,591 compared to average volume of 1,491,767.
Click Here to get the full Stock Report for Fate Therapeutics Inc stock.